A tailored approach to cardioneuroablation for reflex syncope and functional bradycardia: results from the ELEGANCE

Carlo Gigante1,2, Diego Penela3, Daniel Viveros1,2

  • 1Arrhythmia Department, Heart Institute, Teknon Medical Center, c. Villana, 12, Barcelona 08022, Spain.

Insights

A tailored cardioneuroablation (CNA) approach, targeting specific ganglionated plexi (GPs) based on patient symptoms, proved as effective as the standard method. This personalized strategy significantly reduced procedure time and radiofrequency energy use.

Area of Science:

  • Cardiology
  • Autonomic Nervous System Research
  • Electrophysiology

Background:

  • Cardioneuroablation (CNA) modulates the cardiac autonomic nervous system by targeting ganglionated plexi (GPs).
  • Current CNA approaches often involve targeting all accessible GPs.
  • The efficacy of a selective GP targeting strategy based on clinical phenotype remains to be fully elucidated.

Purpose of the Study:

  • To compare a tailored CNA strategy, selectively targeting GPs based on clinical phenotype, against the standard approach of targeting all GPs.
  • To assess procedural efficiency and clinical outcomes between the two strategies.

Main Methods:

  • A prospective, multicenter European study (ELEGANCE) included 123 patients undergoing CNA.
  • Patients were divided into a tailored group (n=54), targeting specific GPs (SPSGP for sinus node dysfunction, IPSGP for AV block), and a standard group (n=69).
  • Procedural data and clinical outcomes, including syncope recurrence and heart rate changes, were compared.

Main Results:

  • The tailored group demonstrated significantly shorter procedure times (63 vs. 85 minutes) and reduced radiofrequency (RF) time (5.4 vs. 10.4 minutes) compared to the standard group.
  • Acute procedural success rates (93% vs. 90%) and heart rate increases (40% vs. 40%) were similar between groups.
  • At a median follow-up of 15.9 months, syncope recurrence rates were comparable, with no significant difference in inappropriate sinus tachycardia incidence.

Conclusions:

  • An individualized CNA strategy, targeting specific GPs based on patient pathophysiology, yields outcomes equivalent to the standard approach.
  • This tailored method enhances procedural efficiency by reducing RF delivery, shortening procedure duration, and limiting the extent of ablation.
  • Selective GP targeting offers a more efficient and potentially less invasive alternative for managing reflex syncope and functional bradyarrhythmias.
Abstract

Related Concept Videos

Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
570
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
385
Decreased pulse rate01:14

Decreased pulse rate

Bradycardia is a medical condition in which the heart rate is slower than normal. It occurs when the heart's natural pacemaker, the sinus node, generates slower electrical impulses than the standard rhythm. In adults, bradycardia is diagnosed when the pulse rate falls below 60 beats per minute, indicating a deviation from the normal heart rate range.
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with...
815
Electrophysiology of Normal Cardiac Rhythm01:19

Electrophysiology of Normal Cardiac Rhythm

The normal cardiac rhythm is a synchronized electrical activity that facilitates the regular and coordinated contraction of the heart muscle. This process is essential for efficient blood circulation throughout the body. The fundamental elements involved in establishing and maintaining this rhythm include the unique electrical properties of cardiac muscle cells, the sinoatrial (SA) node's pacemaker function, the specialized conducting system, and the ionic mechanisms underlying each phase...
8.6K
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
481
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers01:24

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
1.4K